Početna › Fenilketonurija › Texas
Kliničke studije za Fenilketonurija u državi Texas
7 studija za Fenilketonurija traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
- University of Texas Southwestern Medical Center (UTSW), Dallas
U tijeku regrutacijaFaza 1
Od 18 do 69 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT07241234AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
- University or Texas, Southwestern medical Center, Dallas
U tijeku regrutacijaFaza 1/2
Od 18 do 55 godina · Oba spola · Ažurirano 18. kol 2026. · NCT06332807A Study of JNT-517 in Participants With Phenylketonuria (PKU)
- University of Texas Southwestern, Dallas
- University of Texas Health (UTHealth) Science Center at Houston, Houston
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. srp 2026. · NCT06971731Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
- UT Southwestern Medical Center, Dallas
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 17. lip 2026. · NCT07477691A Long-Term Study of JNT-517 in Participants With Phenylketonuria
- Children's Medical Center Dallas, Dallas
- University of Texas Southwestern Medical Center, Dallas
- University of Texas Health (UTHealth) Science Center at Houston, Houston
U tijeku regrutacijaFaza 3
Od 4 godina i više · Oba spola · Ažurirano 1. svi 2026. · NCT06628128A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
- University of Texas Southwestern Medical Center, Dallas
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 25. ožu 2026. · NCT05813678A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
- UT Southwestern Medical Center, Dallas
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 24. ožu 2026. · NCT06305234Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.